Daejeon [South Korea], August 4 (ANI): The US Food and Drug Administration recently approved Aduhelm, a monoclonal antibody that targets amyloid beta (A), as the first Alzheimer's disease treatment (AD). Its impact on cognitive improvement, however, is controversial.
Daejeon [South Korea], August 4 (ANI): The US Food and Drug Administration recently approved Aduhelm, a monoclonal antibody that targets amyloid beta (A), as the first Alzheimer's disease treatment (AD). Its impact on cognitive improvement, however, is controversial.
Daejeon [South Korea], August 4 (ANI): Aduhelm, a monoclonal antibody that targets amyloid beta (A), was recently found by the US Food and Drug Administration as the first treatment for Alzheimer's disease (AD). However, its impact on cognitive improvement is still debatable.
Daejeon [South Korea], August 4 (ANI): Aduhelm, a monoclonal antibody that targets amyloid beta (A), was recently found by the US Food and Drug Administration as the first treatment for Alzheimer's disease (AD). However, its impact on cognitive improvement is still debatable.
Daejeon [South Korea], June 22 (ANI): The number of elderly people suffering from Alzheimer's disease has increased rapidly in recent decades. For a long time, scientists believed that misfolded aggregates of amyloid-beta protein accumulated and formed plaques in the brain, leading to memory loss and nerve cell death. However, recent clinical trial failures indicate an urgent need to understand the missing link between amyloid-beta protein plaques and disease symptoms.
Neymar scored from the penalty spot as Brazil downed the Samurai Blue at the National Stadium in Tokyo after an impressive performance by goalkeeper Shuichi Gonda had frustrated the Paris St Germain striker and his teammates.
Daejeon [South Korea], May 16 (ANI/Global Economic):Astronomers snapped an image of a supermassive black hole for the first time in history. This is the second result of the research team since 2019, when it presented a picture of the M87 black hole. The Korea Astronomy and Space Science Institute (KASI) also participated in the research.
Daejeon [South Korea], November 21 (ANI): While everyone wants to live a long and healthy life, it isn't possible for everyone. However, recent research has highlighted the significance of the tumour suppressor protein PTEN that can increase your health span, when targeted to create therapies to promote a longer life span. This study was conducted under Professor Seung-Jae V. Lee from the Department of Biological Sciences.